Curat Global’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$102K Sell
350
-200
-36% -$65.7K 0.1% 129
2025
Q4
$193K Sell
550
-50
-8% -$16.9K 0.21% 95
2025
Q3
$193K Hold
600
0.18% 97
2025
Q2
$233K Hold
600
0.22% 93
2025
Q1
$261K Buy
+600
New +$241K 0.32% 87

Other funds holding ELV

Curat Global's ELV Position: Q1 2026 in Review

Curat Global reduced its Elevance Health (ELV) stake by 36% in Q1 2026, selling an estimated $65.7K and leaving 350 shares worth $102K. The position accounts for 0.1% of the portfolio, ranked #129.

Curat Global first reported a position in ELV in Q1 2025 and has held it in 5 quarters since. The position peaked at $261K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Curat Global held 350 shares of Elevance Health worth $102K as of Q1 2026.
  • Curat Global sold 200 Elevance Health shares in Q1 2026, an estimated $65.7K.
  • Elevance Health made up 0.1% of Curat Global's portfolio in Q1 2026, its #129 holding.
  • Curat Global first reported a position in Elevance Health in Q1 2025 and has held it in 5 quarters since.
  • Curat Global's Elevance Health position peaked at $261K in Q1 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Curat Global's 13F filing for Q1 2026, filed 21 Apr 2026.